Raymond James Financial Services Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-113,883
| Closed | -$2.69M | – | 3509 |
|
|
2023
Q4 | $2.69M | Buy |
113,883
+12,554
| +12% | +$297K | ﹤0.01% | 1410 |
|
|
2023
Q3 | $1.51M | Buy |
101,329
+3,434
| +4% | +$51.2K | ﹤0.01% | 1663 |
|
|
2023
Q2 | $1.07M | Buy |
97,895
+37,736
| +63% | +$413K | ﹤0.01% | 1889 |
|
|
2023
Q1 | $525K | Buy |
+60,159
| New | +$525K | ﹤0.01% | 2301 |
|
|
2021
Q4 | – | Sell |
-11,091
| Closed | -$40K | – | 3372 |
|
|
2021
Q3 | $40K | Sell |
11,091
-4,829
| -30% | -$17.4K | ﹤0.01% | 3180 |
|
|
2021
Q2 | $69K | Buy |
+15,920
| New | +$69K | ﹤0.01% | 3162 |
|
|
2020
Q4 | – | Sell |
-44,598
| Closed | -$323K | – | 3043 |
|
|
2020
Q3 | $323K | Buy |
+44,598
| New | +$323K | ﹤0.01% | 2231 |
|
|
2020
Q1 | – | Sell |
-13,238
| Closed | -$26K | – | 2853 |
|
|
2019
Q4 | $26K | Buy |
+13,238
| New | +$26K | ﹤0.01% | 2778 |
|
|
2018
Q2 | – | Sell |
-14,422
| Closed | -$187K | – | 2816 |
|
|
2018
Q1 | $187K | Buy |
+14,422
| New | +$187K | ﹤0.01% | 2276 |
|